Effectiveness of Ozone Therapy Versus Pulsed Radiofrequency in Low Back Pain With Radiculopathy
Comparative Effectiveness of Ozone Therapy Versus Pulsed Radiofrequency in Low Back Pain With Radiculopathy: a Retrospective Comparative Study
1 other identifier
interventional
69
1 country
1
Brief Summary
Treatment selection for refractory radicular low back pain is frequently made in the absence of direct comparative evidence between competing minimally invasive options. By placing ozone therapy and PRF side by side within a single clinical service and following patients for six months, this study contributes pragmatic evidence that maps more closely onto everyday decision-making than isolated single-arm reports. The findings carry practical implications for clinicians, patients, and health systems. For clinicians, a clearer understanding of which modality offers more sustained pain relief can inform first-line selection and patient counseling. For patients, improved durability of benefit translates directly into better quality of life, reduced reliance on systemic analgesics, and a lower likelihood of progressing to surgery. For resource-constrained health systems, evidence favoring a lower-cost, well-tolerated, outpatient procedure has clear value for service planning and cost-effectiveness. Finally, by reporting outcomes transparently-including instances where between-group differences did not survive statistical adjustment-this study aims to add measured, reliable evidence to a literature that has at times been limited by small samples, heterogeneous protocols, and short follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable low-back-pain
Started Jul 2026
Shorter than P25 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 14, 2026
CompletedFirst Posted
Study publicly available on registry
August 19, 2026
CompletedAugust 19, 2026
August 1, 2026
1 month
August 14, 2026
August 14, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
pain intensity
measured with the Visual Analog Scale at baseline and at 1,3, and 6 months
6 months
functional disability
measured with the Oswestry Disability Index at baseline and at 1,3, and 6 months
6 months
Secondary Outcomes (1)
Procedure-related complications
6 months
Study Arms (2)
Intradiscal ozone therapy
ACTIVE COMPARATORPulsed radiofrequency
ACTIVE COMPARATORInterventions
Antibiotic prophylaxis was administered with cefazolin 1 g intravenously over 15 minutes, approximately one hour before the procedure. Under fluoroscopic guidance, a 22-gauge, 15-cm Chiba needle was advanced into the target intervertebral disc, and intradiscal placement was confirmed by contrast injection, demonstrating satisfactory spread. Ozone 5 mL at a concentration of 30 µg/mL was injected intradiscally. The needle was then repositioned to the inferior neural foramen (Kambin's triangle); contrast injection confirmed appropriate spread without vascular uptake, and a further 5 mL of ozone at 30 µg/mL was administered into the foraminal/perineural region.
Under fluoroscopic guidance, a radiofrequency needle was advanced to the target safe (supraneural) triangle adjacent to the affected dorsal root ganglion. Correct placement was confirmed in anteroposterior and lateral views, and contrast injection demonstrated appropriate epidural/perineural spread without vascular uptake. Pulsed radiofrequency was applied at 42 °C for 6 minutes, with impedance maintained between 300 and 500 Ω. Following PRF, 3 mL of a mixture containing 40 mg methylprednisolone with lidocaine was injected into the foraminal region.
Eligibility Criteria
You may qualify if:
- Age greater than 18 years.
- Low back and leg pain of more than six weeks' duration.
- Failure to respond to conservative management.
- Grade I-IV disc pathology.
- Unilateral leg pain.
- Three or fewer spinal levels are involved.
You may not qualify if:
- Severe canal or foraminal stenosis.
- Severely dehydrated disc.
- Allergy to antibiotics or contrast media.
- Previous spine surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zagazig Universitylead
- Nizwa Hospital, Sultanate of Omancollaborator
Study Sites (1)
Nizwa Hospital
Nizwa, AL Radah State, 611, Oman
Related Publications (2)
Strand NH, Hagedorn JM, Dunn T, Johnson B, Abd-Elsayed A, Covington S, Freeman J, Dawodu A, Maloney J. Advances in radiofrequency ablation: mechanism of action and technology. Ann Palliat Med. 2024 Jul;13(4):1028-1034. doi: 10.21037/apm-23-457. Epub 2024 Jul 18.
PMID: 39043563BACKGROUNDSam J, Catapano M, Sahni S, Ma F, Abd-Elsayed A, Visnjevac O. Pulsed Radiofrequency in Interventional Pain Management: Cellular and Molecular Mechanisms of Action - An Update and Review. Pain Physician. 2021 Dec;24(8):525-532.
PMID: 34793641BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 14, 2026
First Posted
August 19, 2026
Study Start
July 1, 2026
Primary Completion
August 1, 2026
Study Completion
August 1, 2026
Last Updated
August 19, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 6 months after study publication
- Access Criteria
- by email
The datasets used and/or analyzed during the current study are available from the principal investigator upon reasonable request.